SHMN
SOHM, Inc.
Set alert
0.00 USD 0.00 -14.29%
0.0007 Day range 0.0008
0.0006 52-week range 0.0015
- YTD
- -33.33%
- 1 year
- -52.00%
- Open
- 0.0008
- Prev close
- 0.0007
- Mkt cap
- 1.74M
- Vol
- 1.13M
- Avg vol
- 1.04M
- EPS
- -0.002
- P/E
- 0.00
More statistics
- Low
- 0.0007
- High
- 0.0008
Financials — quick view
SHMN Revenue — quarterly 231.86K
SHMN Net income — quarterly -249.58K
SHMN EPS — quarterly 0.00
News
- SOHM Inc. Releases White Paper on ABBIE, a Cas9-Guided Integrase Enabling Stable Gene Integration and Creation of SKOV3-GYS1 Cell Line for Drug Discovery
- SOHM Notes FDA's Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development
- SOHM, Inc., Moving and Expanding Commercialization Capabilities with its New Vista, CA Facility
- SOHM Achieves Breakthrough with ABBIE Gene Editing Platform, Advancing Strategic Partnership and Licensing Opportunities
- SOHM, Inc. Launches New User-Friendly Website to Enhance Customer, Investor Experience and Engagement
- SOHM, Inc. Appoints Ravi Kapoor as an Independent Director
- SOHM, Inc. Sets Strategic Goals to Enter Biotechnology-Driven Cosmeceuticals Market
- SOHM Inc. Welcomes Dr. Larissa Karnaoukhova as New Vice President of Operations
- SOHM Inc. Welcomes Dr. Lucia Piccotti to Offer Expert Guidance on Cosmeceutical and Personal Health Product Research and Development
- SOHM, Inc., Unveils Genetically Engineered Ovarian Cancer Cell Line Using ABBIE(TM) Platform to Accelerate GYS1 Drug Discovery
Your note
Sign in to keep a note on SHMN — it syncs with the Stock Master app.